Suchergebnisse - "Suda, Goki"

PubPharm (200)

1

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

2

Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan : Updated nationwide survey from 2018 to 2021

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Enomoto, H. | Akuta, N. | Hikita, H. | +10

3

α-FAtE : A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

enthalten in: International journal of cancer | 2024

von Rossari, F. | Tada, T. | Suda, G. | +70

4

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Targeted oncology | 2024

von Camera, S. | Rimini, M. | Rossari, F. | +73

5

Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

enthalten in: Journal of gastroenterology | 2023

von Tahata, Y. | Hikita, H. | Mochida, S. | +35

6

Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Sasaki, T. | Suda, G. | Ohara, M. | +18

7

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Persano, M. | Rimini, M. | Tada, T. | +76

CommentIn: Eur J Cancer. 2023 Oct;192:113264. - PMID 37620209

8

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients

enthalten in: Journal of cancer research and clinical oncology | 2023

von Rimini, M. | Persano, M. | Tada, T. | +65

9

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma : a multicenter real-world study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Persano, M. | Rimini, M. | Tada, T. | +77

10

Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Tokuchi, Y. | Suda, G. | Kawagishi, N. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]